Materialise NV (MTLS)

NMS – Real Time Price. Currency in USD

5.80

+0.33 (6.03%)

At close: May 12, 2026, 4:00 PM EDT

5.71

-0.09 (-1.55%)

Pre-market: May 13, 2026, 6:28 AM EDT

08.05.2026

Materialise Q1 Earnings Call Highlights

Materialise NASDAQ: MTLS reported first-quarter 2026 revenue of EUR 66.3 million, which Chief Financial Officer Koen Berges said was stable year-over-year despite “significant foreign exchange headwinds,” primarily tied to a weaker U.S. dollar. Gross profit rose to EUR 37.9 million and gross margin expanded to 57.2%, helping drive improved profitability and positive free cash flow during the period.

07.05.2026

Materialise NV (MTLS) Q1 2026 Earnings Call Transcript

07.05.2026

Materialise Reports First Quarter 2026 Results

LEUVEN, Belgium--(BUSINESS WIRE)--Materialise NV (Euronext & NASDAQ:MTLS), a global leader in 3D-printed medical devices and software, and a pioneer in additive manufacturing software and services, today announced its financial results for the first quarter ended March 31, 2026. Additionally, Materialise announced the transfer of its eyewear business to the eyewear management team. Highlights – First Quarter 2026 Total revenue was stable at 66,276 kEUR for the first quarter of 2026 compared.

29.04.2026

Materialise: The Medical Segment Alone Makes This A Buy

Materialise receives a 'Buy' rating, driven by robust growth in its medical segment despite weakness in software and manufacturing. MTLS's medical segment boasts a 4-year CAGR of 16%, with management guiding for continued strong growth through FY2026. The company maintains a fortress balance sheet with €71m net cash and trades at a significant discount to sector peers on EV/Sales and EV/EBITDA.

23.04.2026

Materialise NV to Report First Quarter 2026 Earnings on Thursday, May 7, 2026

LEUVEN, Belgium--(BUSINESS WIRE)--Materialise NV (Euronext & NASDAQ: MTLS), a global leader in 3D-printed medical devices and software, and a pioneer in additive manufacturing software and services, today announced that it will release financial results for the first quarter ended March 31, 2026 on Thursday, May 7, 2026 at 1:00 a.m. ET/7:00 a.m. CET. Senior management will hold a conference call to discuss the first quarter 2026 financial results on Thursday, May 7, 2026 at 8:30 a.m. ET/2:3.

31.03.2026

Materialise to Transfer RapidFit Business to Its Management Team

Leuven (BELGIUM), March 31, 2026 (GLOBE NEWSWIRE) -- Materialise NV (Euronext & Nasdaq: MTLS), a global leader in 3D-printed medical devices and software, and a pioneer in additive manufacturing software and services, announces the decision to transfer its RapidFit business to its management team. Following the transaction, RapidFit will continue as an independent company under the ownership and leadership of the same team under the RapidFit name.

24.02.2026

Materialise: Medical And Software-Led Rebound

Materialise is poised for a return to consistent growth and improving margins, led by Medical strength and stabilization of its Software business. The Manufacturing segment faces ongoing headwinds, but expansion into aerospace and defense could create a modest rebound over the next few years. The combination of a low valuation, consistent growth, and higher margins should lead the stock higher, which will be supported by a share buyback program.

Videos

No Data

There is no data to display

Materialise Reports Fourth Quarter and Full Year 2025 Results

LEUVEN, Belgium--(BUSINESS WIRE)---- $MTLS--Materialise NV (Euronext & NASDAQ:MTLS), a global leader in 3D-printed medical devices and software, and a pioneer in additive manufacturing software and services, today announced its financial results for the fourth quarter and full year ended December 31, 2025. Highlights – Fourth Quarter 2025 Total revenue increased by 6.8% to 70,164 kEUR for the fourth quarter of 2025 from 65,680 kEUR for the corresponding 2024 period, boosted by 16.3% growth in our Mat.

20.11.2025

Materialise Successfully Launched on Euronext Brussels – Information on the Total Number of Voting Rights and Shares

LEUVEN, Belgium--(BUSINESS WIRE)--Materialise NV (Euronext & Nasdaq: MTLS), a global leader in 3D-printed medical devices and software, and a pioneer in additive manufacturing software and services, today announced the start of its additional listing of its ordinary shares on Euronext Brussels, to complement the existing Nasdaq listing of its American depositary shares (ADSs) representing ordinary shares. The additional listing and trading of the Materialise shares on Euronext Brussels will.

Materialise NV (MTLS)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Materialise NV (MTLS)

Materialise Q1 Earnings Call Highlights

Materialise NV (MTLS) Q1 2026 Earnings Call Transcript

Materialise Reports First Quarter 2026 Results

Materialise: The Medical Segment Alone Makes This A Buy

Materialise NV to Report First Quarter 2026 Earnings on Thursday, May 7, 2026

Materialise to Transfer RapidFit Business to Its Management Team

Materialise: Medical And Software-Led Rebound

Videos

No Data

Press releases

Materialise Reports First Quarter 2026 Results

Materialise to Transfer RapidFit Business to Its Management Team

Materialise Reports Fourth Quarter and Full Year 2025 Results

Materialise Successfully Launched on Euronext Brussels – Information on the Total Number of Voting Rights and Shares

Materialise Q1 Earnings Call Highlights

Materialise NV (MTLS) Q1 2026 Earnings Call Transcript

Materialise Reports First Quarter 2026 Results

Materialise: The Medical Segment Alone Makes This A Buy

Materialise NV to Report First Quarter 2026 Earnings on Thursday, May 7, 2026

Materialise to Transfer RapidFit Business to Its Management Team

Materialise: Medical And Software-Led Rebound

Videos

No Data

Press releases

Materialise Reports First Quarter 2026 Results

Materialise to Transfer RapidFit Business to Its Management Team

Materialise Reports Fourth Quarter and Full Year 2025 Results

Materialise Successfully Launched on Euronext Brussels – Information on the Total Number of Voting Rights and Shares

Search stocks

Materialise NV (MTLS)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Materialise NV (MTLS)

Materialise Q1 Earnings Call Highlights

Materialise NV (MTLS) Q1 2026 Earnings Call Transcript

Materialise Reports First Quarter 2026 Results

Materialise: The Medical Segment Alone Makes This A Buy

Materialise NV to Report First Quarter 2026 Earnings on Thursday, May 7, 2026

Materialise to Transfer RapidFit Business to Its Management Team

Materialise: Medical And Software-Led Rebound

Videos

No Data

Press releases

Materialise Reports First Quarter 2026 Results

Materialise to Transfer RapidFit Business to Its Management Team

Materialise Reports Fourth Quarter and Full Year 2025 Results

Materialise Successfully Launched on Euronext Brussels – Information on the Total Number of Voting Rights and Shares

Materialise Q1 Earnings Call Highlights

Materialise NV (MTLS) Q1 2026 Earnings Call Transcript

Materialise Reports First Quarter 2026 Results

Materialise: The Medical Segment Alone Makes This A Buy

Materialise NV to Report First Quarter 2026 Earnings on Thursday, May 7, 2026

Materialise to Transfer RapidFit Business to Its Management Team

Materialise: Medical And Software-Led Rebound

Videos

No Data

Press releases

Materialise Reports First Quarter 2026 Results

Materialise to Transfer RapidFit Business to Its Management Team

Materialise Reports Fourth Quarter and Full Year 2025 Results

Materialise Successfully Launched on Euronext Brussels – Information on the Total Number of Voting Rights and Shares